z-logo
Premium
Poster — Thur Eve — 39: Feasibility of Commissioning HybridArc with the Delta 4 two plane diode phantom: comparisons with Gafchromic Film.
Author(s) -
Bojechko C.,
Ploquin N.,
Hudson A.,
Sayous Y.
Publication year - 2014
Publication title -
medical physics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 180
eISSN - 2473-4209
pISSN - 0094-2405
DOI - 10.1118/1.4894899
Subject(s) - imaging phantom , linear particle accelerator , dosimetry , nuclear medicine , physics , medical physics , radiation treatment planning , optics , radiation therapy , medicine , beam (structure) , radiology
HybridArc is a relatively novel radiation therapy technique which combines optimized dynamic conformai arcs (DCA) and intensity modulated radiation therapy (IMRT). HybridArc has possible dosimetry and efficiency advantages over stand alone DCA and IMRT treatments and can be readily implemented on any linac capable of DCA and IMRT, giving strong motivation to commission the modality. The Delta4 phantom (Scandidos, Uppsala, Sweden) has been used for IMRT and VMAT clinical dosimetric verification making it a candidate for HybridArc commissioning. However the HybridArc modality makes use of several non co‐planar arcs which creates setup issues due to the geometry of the Delta4, resulting in possible phantom gantry collisions for plans with non‐zero couch angles. An analysis was done determining the feasibility of using the Delta4 fixed at 0° couch angle compared with results obtained using Gafchromic ETB2 film (Ashland, Covington Kentucky) in an anthropomorphic phantom at the planned couch angles. A gamma index analysis of the measured and planned dose distributions was done using Delta4 and DoseLab Pro (Mobius Medical Systems, Houston Texas) software. For both arc and IMRT sub‐fields there is reasonable correlation between the gamma index found from the Delta4 and Gafchromic film. All results show the feasibility of using the Delta4 for HybridArc commissioning.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here